Compare Abeona Therapeutics Inc (ABEO) vs Booz Allen Hamilton Holding Corporation (BAH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs Booz Allen Hamilton Holding Corporation — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Booz Allen Hamilton Holding Corporation trades at $78.36 (market cap $9.45B). The key difference: Booz Allen Hamilton Holding Corporation is far larger — about 22.4× Abeona Therapeutics Inc's market cap, and Booz Allen Hamilton Holding Corporation pays a 3% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | BAH | |
|---|---|---|
Market Cap | $421.19M | $9.45B |
Sector | Health | Industrials |
52-Week High | $7.45 | $111.63 |
52-Week Low | $4.17 | $59.71 |
Enterprise Value | $276.10M | $13.07B |
Dividend Yield | — | 3% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Booz Allen Hamilton Holding Corporation
Booz Allen Hamilton Holding Corp is a provider of management consulting services to the U.S. government. Other services offered include technology, such as cloud computing and cybersecurity consulting, and engineering consulting. The consulting services are focused on defense, intelligence, and civil markets. In addition to the U.S. government, Booz Allen Hamilton provides its management and technology consulting services to large corporations, institutions, and nonprofit organizations. The company assists clients in long-term engagements around the globe.
Read more on BAH →
